Source/Disclosures
Source: Healio Coverage
October 21, 2020
1 min read
Save

Top in endocrinology: Vitamin D supplementation, HbA1c reduction

Source/Disclosures
Source: Healio Coverage
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Higher-dose vitamin D supplementation may be a “promising approach” to reducing the risk for type 2 diabetes among adults with prediabetes, according to researchers. This was the top story in endocrinology last week.

Another top story was about an investigational once-daily pill that reduced HbA1c among certain adults with type 1 diabetes.

Vitamin D Pills
Source: Adobe Stock

Read these and more top stories in endocrinology below:

Higher-dose vitamin D ‘promising approach’ to prevent type 2 diabetes

Daily vitamin D supplementation to achieve blood levels of vitamin D higher than typically recommended for bone health may reduce risk for type 2 diabetes among adults with prediabetes, according to a new analysis of the D2d study. Read more.

Investigational once-daily pill reduces HbA1c in type 1 diabetes, without hypoglycemia

An investigational once-daily pill added to optimized insulin therapy was shown to reduce HbA1c among adults with type 1 diabetes during a 12-week trial when compared with placebo plus insulin, according to a presenter at the European Association for the Study of Diabetes meeting. Read more.

Make an IMPACT: Leverage physician, mom identities to fight ‘infodemic’ during COVID-19

Fighting medical misinformation is an urgent priority during the COVID-19 pandemic, and physician mothers are uniquely positioned to leverage dual identities to help the public and policymakers discern what is true, according to a speaker at the virtual Women in Medicine Summit. Read more.

Bariatric surgery increases life expectancy vs. usual obesity care

Life expectancy increased by 3 years for adults with obesity who had bariatric surgery compared with usual care; however, life expectancy was still shorter than that for the general population, according to researchers in Sweden. Read more.

Antibody response in COVID-19 similar in adults with and without diabetes

Antibodies in adults with diabetes hospitalized with COVID-19 in Italy had a similar positive response to the SARS-CoV-2 spike protein as those without diabetes, according to findings published in Diabetologia. Read more.